Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data.


Kimyon G., Kalyoncu U., Kiraz S., Bes C., Coşkun N. , Yağiz B., ...More

Clinical and experimental rheumatology, vol.39, pp.852-858, 2021 (Journal Indexed in SCI Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 39
  • Publication Date: 2021
  • Title of Journal : Clinical and experimental rheumatology
  • Page Numbers: pp.852-858